13F Filings History of Invenomic Capital Management LP

Latest 13F report
Q3 2025 - 14 Nov 2025
Value $
$1,912,018,073
Signature - Title
Nicholas Harris - Chief Compliance Officer
Location
Boston, MA
Summary
This page shows a list of all the recent 13F filings made by Invenomic Capital Management LP. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Invenomic Capital Management LP reported 141 stock holdings with total value $1,912,018,073 as of Q3 2025. Top holdings included GPN, XRAY, EGO, VTRS, and ACHC.

Notify me when Invenomic Capital Management LP files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 141 $1,912,018,073 +$576,738,260 -$548,514,880 +$28,223,380 GPN, XRAY, EGO, VTRS, ACHC 13F-HR 14 Nov 2025, 16:00
Q2 2025 148 $1,761,768,140 +$467,451,673 -$749,575,771 -$282,124,098 GPN, XRAY, VTRS, EGO, RNG 13F-HR 14 Aug 2025, 16:00
Q1 2025 168 $1,966,995,042 +$844,779,431 -$513,714,826 +$331,064,605 VTRS, AKAM, GPN, TFX, LYFT 13F-HR 15 May 2025, 16:00
Q4 2024 153 $1,778,419,701 +$503,360,032 -$529,191,326 -$25,831,294 GPN, XRAY, ES, VTRS, TAP 13F-HR 14 Feb 2025, 16:00
Q3 2024 141 $1,811,447,452 +$448,725,468 -$684,578,051 -$235,852,583 GPN, MTB, LYFT, VTRS, ZM 13F-HR 14 Nov 2024, 16:00
Q2 2024 157 $1,918,661,985 +$669,745,216 -$486,143,237 +$183,601,979 ES, CHRD, GPN, T, VTRS 13F-HR 14 Aug 2024, 16:00
Q1 2024 145 $1,880,230,858 +$620,212,778 -$631,362,104 -$11,149,326 CHRD, CLVT, VTRS, SSNC, T 13F-HR 15 May 2024, 16:00
Q4 2023 166 $1,875,316,517 +$582,427,816 -$1,359,738,816 -$777,311,000 VTRS, SSNC, ILMN, CLVT, CHRD 13F-HR 14 Feb 2024, 12:00
Q3 2023 145 $2,380,552,295 +$970,146,999 -$309,329,507 +$660,817,492 SPY, AAPL, VTRS, C, BMY 13F-HR 14 Nov 2023, 14:38
Q2 2023 132 $1,791,714,025 +$401,564,545 -$417,897,120 -$16,332,575 CLVT, FLT, VTRS, WEX, SSNC 13F-HR 14 Aug 2023, 16:58
Q1 2023 138 $1,755,450,400 +$711,873,562 -$461,792,706 +$250,080,856 FLT, CLVT, SSNC, DBX, CMCSA 13F-HR 15 May 2023, 10:06
Q4 2022 137 $1,380,442,994 +$516,256,979 -$388,467,368 +$127,789,611 APP, FTDR, IPGP, LYFT, EBAY 13F-HR 14 Feb 2023, 11:12
Q3 2022 145 $1,159,697,000 +$467,377,195 -$407,867,786 +$59,509,409 DBX, UHS, T, EBAY, CMCSA 13F-HR 14 Nov 2022, 16:09
Q2 2022 143 $1,152,317,000 +$558,281,595 -$151,420,693 +$406,860,902 UHS, T, CMCSA, DBX, WBD 13F-HR 15 Aug 2022, 13:50
Q1 2022 147 $604,614,000 +$367,400,330 -$80,418,220 +$286,982,110 T, DBX, ATGE, POSH, HRB 13F-HR 16 May 2022, 12:10
Q4 2021 138 $425,534,000 +$219,283,752 -$75,408,842 +$143,874,910 LRN, HRB, T, BPOP, RGA 13F-HR 11 Feb 2022, 17:09
Q3 2021 115 $281,096,000 +$102,856,639 -$41,030,830 +$61,825,809 HRB, LRN, GTS, BCEI, KOP 13F-HR 15 Nov 2021, 17:31
Q2 2021 114 $225,231,000 +$75,469,341 -$67,775,133 +$7,694,208 LRN, HRB, BCEI, KGC, TECK 13F-HR 16 Aug 2021, 14:53
Q1 2021 109 $206,929,000 +$78,997,744 -$70,403,437 +$8,594,307 HRB, TZOO, BCEI, KGC, MG 13F-HR 13 May 2021, 14:10
Q4 2020 128 $167,078,000 +$58,819,564 -$75,473,080 -$16,653,516 HRB, KGC, LRN, HSII, CHL 13F-HR 17 Feb 2021, 08:03
Q3 2020 130 $138,731,000 +$53,498,875 -$57,530,744 -$4,031,869 HRB, HSII, SKT, DHIL, UGI 13F-HR 13 Nov 2020, 10:59
Q2 2020 147 $134,595,000 +$36,219,268 -$49,097,185 -$12,877,917 LRN, UGI, DHIL, MIK, NOMD 13F-HR 13 Aug 2020, 15:54
Q1 2020 145 $119,142,000 +$49,139,067 -$102,142,699 -$53,003,632 LRN, AAWW, IDCC, RMR, UGI 13F-HR 13 May 2020, 16:47
Q4 2019 113 $246,640,000 $0 $0 $0 BHC, JBLU, AAWW, RJF, SAVE 13F-HR 14 Feb 2020, 09:47